Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chan

Showing results (1321-1330 of 1,535) with videos related to

Pageof 154
Sort By:
Journal of the American Heart Association|March 10, 2026
Specific Deficiency of Naïve CD4+ T Lymphocytes Characterizes Heart Failure and Heightens Mortality Risk in the HRSDavid A Zidar, Michael L Freeman, Brigid M Wilson, et al.
Journal of Clinical Microbiology|July 28, 2021
Trichomonas vaginalis Detection in Urogenital Specimens from Symptomatic and Asymptomatic Men and Women by Use of the cobas TV/MG TestBarbara Van Der Pol, Arundhati Rao, Melinda B Nye, et al.
Science Immunology|September 15, 2019
RIG-I activation is critical for responsiveness to checkpoint blockadeSimon Heidegger, Alexander Wintges, Florian Stritzke, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 23, 2011
Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong KongN-M T Luk, M Hui, H-C S Lee, et al.
Endocrinology|May 29, 2004
Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivoJillian Cornish, Karen E Callon, Dorit Naot, et al.
PEC Innovation|December 19, 2022
Barriers to family history collection among Spanish-speaking primary care patients: a BRIDGE qualitative studyErica Liebermann, Peter Taber, Alexis S Vega, et al.
Science Translational Medicine|August 5, 2011
Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethalityDenise A Chan, Patrick D Sutphin, Phuong Nguyen, et al.
British Journal of Cancer|May 19, 2023
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomasNitya Raj, Jennifer A Chan, Stephanie J Wang, et al.
Pancreas|April 18, 2013
Consensus guidelines for the management and treatment of neuroendocrine tumorsPamela L Kunz, Diane Reidy-Lagunes, Lowell B Anthony, et al.
The Oncologist|April 13, 2013
Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancerBrian M Wolpin, Kimmie Ng, Andrew X Zhu, et al.
Pageof 154

Showing results (1321-1330 of 1,535) with videos related to

Sort By:
Pageof 154
Journal of the American Heart Association|March 10, 2026
Specific Deficiency of Naïve CD4+ T Lymphocytes Characterizes Heart Failure and Heightens Mortality Risk in the HRSDavid A Zidar, Michael L Freeman, Brigid M Wilson, et al.
Journal of Clinical Microbiology|July 28, 2021
Trichomonas vaginalis Detection in Urogenital Specimens from Symptomatic and Asymptomatic Men and Women by Use of the cobas TV/MG TestBarbara Van Der Pol, Arundhati Rao, Melinda B Nye, et al.
Science Immunology|September 15, 2019
RIG-I activation is critical for responsiveness to checkpoint blockadeSimon Heidegger, Alexander Wintges, Florian Stritzke, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|November 23, 2011
Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong KongN-M T Luk, M Hui, H-C S Lee, et al.
Endocrinology|May 29, 2004
Lactoferrin is a potent regulator of bone cell activity and increases bone formation in vivoJillian Cornish, Karen E Callon, Dorit Naot, et al.
PEC Innovation|December 19, 2022
Barriers to family history collection among Spanish-speaking primary care patients: a BRIDGE qualitative studyErica Liebermann, Peter Taber, Alexis S Vega, et al.
Science Translational Medicine|August 5, 2011
Targeting GLUT1 and the Warburg effect in renal cell carcinoma by chemical synthetic lethalityDenise A Chan, Patrick D Sutphin, Phuong Nguyen, et al.
British Journal of Cancer|May 19, 2023
Pembrolizumab alone and pembrolizumab plus chemotherapy in previously treated, extrapulmonary poorly differentiated neuroendocrine carcinomasNitya Raj, Jennifer A Chan, Stephanie J Wang, et al.
Pancreas|April 18, 2013
Consensus guidelines for the management and treatment of neuroendocrine tumorsPamela L Kunz, Diane Reidy-Lagunes, Lowell B Anthony, et al.
The Oncologist|April 13, 2013
Multicenter phase II study of tivozanib (AV-951) and everolimus (RAD001) for patients with refractory, metastatic colorectal cancerBrian M Wolpin, Kimmie Ng, Andrew X Zhu, et al.
Pageof 154